# Epigno Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/epigno-co

- Industry: Software
- Headquarters: Tokyo, Japan
- Website: www.epigno.jp/
- Total disclosed funding: $0.9M
- Latest round: Series A (Jan 31, 2020)
- Investors on record: 4

## About

Based in Japan, Epigno Co., Ltd. specializes in providing human resource management solutions specifically designed for the healthcare and nursing care sectors, aiming to streamline operations and enhance employee satisfaction.Epigno Co., Ltd. was founded in 2016 and is located in Tokyo, Japan. The company focuses on delivering innovative HR solutions for the healthcare industry. The CEO is Fumiyoshi Inui, who has a background that supports the company's mission. Epigno has participated in 3 investment deals, with a total amount raised of JPY 250.000 mn in its latest funding round, Series B, which was completed on June 5, 2025.Epigno Co., Ltd. specializes in human resource management solutions tailored specifically for the healthcare and nursing care sectors. Their core product offerings include Epital HR and Epitac, both designed to alleviate the operational burdens faced by healthcare providers and improve employee retention rates. These services focus on enhancing the management of medical and caregiving personnel through detailed assessments, educational initiatives, and fostering organizational engagement and motivation. The Epital HR solution supports healthcare facilities by streamlining staff evaluations and training, while Epitac is tailored for home medical care businesses, addressing the specific challenges faced by their staff. Epigno primarily caters to clients within Japan's healthcare industry, which includes hospitals, clinics, and nursing care facilities, aiming to enhance the well-being of healthcare workers, thereby benefiting future patients and their families.Epigno operates a B2B model, providing its services through a subscription-based structure to healthcare organizations. Clients engage with Epigno by subscribing to its solutions, allowing them to implement advanced human resource management practices tailored to their needs. The revenue streams are generated from ongoing partnerships with these institutions, where they pay for access to both Epital HR and Epitac services. This transaction structure establishes a recurring revenue model, ensuring consistent engagement and support for the client organizations. While specific pricing details for these services have not been disclosed, the company focuses on delivering value through tailored solutions that enhance workforce productivity and satisfaction within the healthcare sector.Following the recent acquisition in May 2025, where EUCALIA Inc. agreed to acquire a 62.3% majority stake in Epigno Co., Ltd., the company aims to leverage this partnership to further develop HR and staffing support services for the healthcare industry. The new collaboration is expected to enhance Epigno's product offerings and market reach. The recent funding will be utilized to support these initiatives, ensuring that Epigno remains at the forefront of HR solutions tailored for healthcare, with plans to expand its presence beyond Japan into new markets.

## Funding rounds

- Series A, Jan 31, 2020, $0.9M — MIRAIDOOR, Colopl Next, TOHOKU University Venture Partners, Capital Medica Ventures

## Investors

- MIRAIDOOR (https://capitalatlas.ai/funds/miraidoor) — Series A
- Colopl Next (https://capitalatlas.ai/funds/colopl-next) — Series A
- TOHOKU University Venture Partners (https://capitalatlas.ai/funds/tohoku-university-venture-partners) — Series A
- Capital Medica Ventures (https://capitalatlas.ai/funds/capital-medica-ventures) — Series A